7Baggers
 published on: 2025-09-16 08:58:40  newser.com Tue, 16 Sep 2025 13:58:40 GMT
 published on: 2025-09-15 20:58:57  newser.com Tue, 16 Sep 2025 01:58:57 GMT
 published on: 2025-09-15 20:22:40  newser.com Tue, 16 Sep 2025 01:22:40 GMT
 published on: 2025-09-15 14:22:27  newser.com Mon, 15 Sep 2025 19:22:27 GMT
 published on: 2025-09-14 11:49:36  newser.com Sun, 14 Sep 2025 16:49:36 GMT
 published on: 2025-09-13 15:29:33  newser.com Sat, 13 Sep 2025 20:29:33 GMT
 published on: 2025-09-12 06:01:08  Newser Fri, 12 Sep 2025 11:01:08 GMT
 published on: 2025-09-12 04:28:28  Newser Fri, 12 Sep 2025 09:28:28 GMT
 published on: 2025-09-10 05:32:33  Newser Wed, 10 Sep 2025 10:32:33 GMT
 published on: 2025-09-10 02:39:08  Newser Wed, 10 Sep 2025 07:39:08 GMT
 published on: 2025-09-09 06:58:21  Newser Tue, 09 Sep 2025 11:58:21 GMT
 published on: 2025-09-09 01:00:23  Newser Tue, 09 Sep 2025 06:00:23 GMT
 published on: 2025-09-08 06:27:23  Newser Mon, 08 Sep 2025 11:27:23 GMT
 published on: 2025-09-07 06:33:18  Newser Sun, 07 Sep 2025 11:33:18 GMT
 published on: 2025-09-07 06:22:03  Newser Sun, 07 Sep 2025 11:22:03 GMT
 published on: 2025-09-06 22:03:03  Newser Sun, 07 Sep 2025 03:03:03 GMT
 published on: 2025-09-06 21:39:34  Newser Sun, 07 Sep 2025 02:39:34 GMT
 published on: 2025-09-06 13:11:05  Newser Sat, 06 Sep 2025 18:11:05 GMT
 published on: 2025-09-04 00:46:07  Newser Thu, 04 Sep 2025 05:46:07 GMT
 published on: 2025-09-03 06:54:58  Newser Wed, 03 Sep 2025 11:54:58 GMT
 published on: 2025-09-03 06:50:35  Newser Wed, 03 Sep 2025 11:50:35 GMT
 published on: 2025-09-03 00:53:52  Newser Wed, 03 Sep 2025 05:53:52 GMT
 published on: 2025-09-02 13:32:54  Newser Tue, 02 Sep 2025 18:32:54 GMT
 published on: 2025-09-02 04:09:43  Newser Tue, 02 Sep 2025 09:09:43 GMT

Hepion Pharmaceuticals, Inc
(NASDAQ:HEPA) 

HEPA stock logo

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways inv...

Founded: 2013
Full Time Employees: 12
CEO: Robert Foster  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends